Story preview
Continue reading on the publisher site for the full article.
Read on publisher →Blavity News
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
13
in the last 3 days
First reported
14 hr. ago
12 outlets since
Countries
12 other outlets reported this story in the last 3 days.
Discover how the daily Foundayo weight loss pill is reshaping obesity treatment, accessibility and metabolic health.
Foundayo won backing from a key EU regulator, setting up a potential challenge to Novo Nordisk
The EU drug regulator recommended Eli Lilly's weight-loss pill Foundayo for approval Friday, setting it up to be the second GLP-1 pill approved in the bloc.